|GenoMed, Inc. (Pink Sheets:GMED) today (..26NOV01..) announced that it had finalized a Letter of Intent to acquire|
Genomic Medicine, LLC, a St. Louis, Missouri based genomic biotechnology company.
GenoMed officials indicated that an announcement specific to the finalization of
the acquisition of Genomic Medicine, LLC was expected within ten (10) days.
For additional information please visit genomedics.com and/or contact
Craig Hall @ 941.366.6677 or email at firstname.lastname@example.org.
(....sorta like DNAP, but different....)